Prognostic factors in MCL
Variable . | Univariate analysis . | Multivariate analysis . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P value . | HR . | 95% CI . | P value . | |
Age (per year) | 1.06* | 1.05-1.07 | <.001 | 1.06* | 1.05-1.07 | <.001 |
Male gender | 1.04 | 0.89-1.22 | .642 | 1.36* | 1.12-1.64 | .002 |
WHO performance status | 1.92* | 1.81-2.05 | <.001 | 1.61* | 1.47-1.76 | <.001 |
Elevated LDH | 1.93* | 1.66-2.23 | <.001 | 1.86* | 1.55-2.22 | <.001 |
Ann Arbor stage | 1.26* | 1.17-1.41 | <.001 | 1.21* | 1.07-1.35 | .002 |
White blood cell count (per 1 × 109/L) | 1.002* | 1.001-1.003 | .005 | 1.002* | 1.001-1.004 | .003 |
Variable . | Univariate analysis . | Multivariate analysis . | ||||
---|---|---|---|---|---|---|
HR . | 95% CI . | P value . | HR . | 95% CI . | P value . | |
Age (per year) | 1.06* | 1.05-1.07 | <.001 | 1.06* | 1.05-1.07 | <.001 |
Male gender | 1.04 | 0.89-1.22 | .642 | 1.36* | 1.12-1.64 | .002 |
WHO performance status | 1.92* | 1.81-2.05 | <.001 | 1.61* | 1.47-1.76 | <.001 |
Elevated LDH | 1.93* | 1.66-2.23 | <.001 | 1.86* | 1.55-2.22 | <.001 |
Ann Arbor stage | 1.26* | 1.17-1.41 | <.001 | 1.21* | 1.07-1.35 | .002 |
White blood cell count (per 1 × 109/L) | 1.002* | 1.001-1.003 | .005 | 1.002* | 1.001-1.004 | .003 |
P < .01.